GILD in the 13F filings
Gilead Sciences Inc · CUSIP 375558103
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 22 Jan 2026
- Managers listing it
- 34
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 22 listed it in both
- Shares listed
- 281,057,316
- combined, among listed positions
- Reported value
- $34.5bn
- combined, at the quarter end
Among the 92 comparable managers: 18 buyers (opened or added shares) and 19 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +13,598,821.
Managers listing GILD in Q4 2025
34 of 34 holders
Largest increases and reductions, by shares
Increases
- Invesco Ltdexisting position · 43,457,808 shares now+28,318,127
- Fidelity (FMR LLC)existing position · 65,579,490 shares now+5,263,211
- MFS Investment Managementexisting position · 4,223,304 shares now+4,113,999
- Holocene Advisors LPexisting position · 4,164,438 shares now+1,547,266
- T. Rowe Price Associates Incexisting position · 27,698,660 shares now+1,195,269
Reductions
- Wellington Management Group LLPexisting position · 15,907,304 shares now-9,711,230
- Capital Research Global Investorsexisting position · 25,307,071 shares now-4,706,975
- Dodge & Coxexisting position · 26,283,511 shares now-3,849,620
- Renaissance Technologies LLCexisting position · 2,788,728 shares now-2,674,016
- Capital World Investorsexisting position · 42,872,129 shares now-2,307,802
New positions and exits
New (1)
Exited (3)
- Schonfeld Strategic Advisors LLCwas $28m
- Tudor Investment Corpwas $14m
- Quantbot Technologies LPwas $72k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 22 | $26.4bn | n.a. | n.a. |
| Q3 2013 | 20 | $31.7bn | n.a. | n.a. |
| Q4 2013 | 24 | $35.6bn | n.a. | n.a. |
| Q1 2014 | 26 | $30.7bn | n.a. | n.a. |
| Q2 2014 | 26 | $35.5bn | n.a. | n.a. |
| Q3 2014 | 28 | $40.8bn | n.a. | n.a. |
| Q4 2014 | 30 | $30.9bn | n.a. | n.a. |
| Q1 2015 | 32 | $31.9bn | n.a. | n.a. |
| Q2 2015 | 31 | $36.4bn | n.a. | n.a. |
| Q3 2015 | 31 | $27.6bn | n.a. | n.a. |
| Q4 2015 | 34 | $25.0bn | n.a. | n.a. |
| Q1 2016 | 35 | $18.5bn | n.a. | n.a. |
| Q2 2016 | 33 | $15.5bn | n.a. | n.a. |
| Q3 2016 | 30 | $12.9bn | n.a. | n.a. |
| Q4 2016 | 33 | $11.4bn | n.a. | n.a. |
| Q1 2017 | 33 | $9.9bn | n.a. | n.a. |
| Q2 2017 | 33 | $10.4bn | n.a. | n.a. |
| Q3 2017 | 27 | $12.4bn | n.a. | n.a. |
| Q4 2017 | 28 | $12.3bn | n.a. | n.a. |
| Q1 2018 | 32 | $14.0bn | n.a. | n.a. |
| Q2 2018 | 29 | $13.6bn | n.a. | n.a. |
| Q3 2018 | 29 | $15.6bn | n.a. | n.a. |
| Q4 2018 | 32 | $13.3bn | n.a. | n.a. |
| Q1 2019 | 32 | $14.9bn | n.a. | n.a. |
| Q2 2019 | 29 | $16.1bn | n.a. | n.a. |
| Q3 2019 | 30 | $13.9bn | n.a. | n.a. |
| Q4 2019 | 32 | $14.3bn | n.a. | n.a. |
| Q1 2020 | 28 | $17.0bn | n.a. | n.a. |
| Q2 2020 | 23 | $18.7bn | n.a. | n.a. |
| Q3 2020 | 25 | $14.2bn | n.a. | n.a. |
| Q4 2020 | 27 | $13.4bn | n.a. | n.a. |
| Q1 2021 | 24 | $14.5bn | n.a. | n.a. |
| Q2 2021 | 18 | $14.9bn | n.a. | n.a. |
| Q3 2021 | 20 | $16.4bn | n.a. | n.a. |
| Q4 2021 | 20 | $16.8bn | n.a. | n.a. |
| Q1 2022 | 28 | $13.2bn | n.a. | n.a. |
| Q2 2022 | 26 | $13.6bn | n.a. | n.a. |
| Q3 2022 | 24 | $13.3bn | n.a. | n.a. |
| Q4 2022 | 32 | $21.1bn | n.a. | n.a. |
| Q1 2023 | 27 | $21.8bn | n.a. | n.a. |
| Q2 2023 | 24 | $20.7bn | n.a. | n.a. |
| Q3 2023 | 24 | $20.0bn | n.a. | n.a. |
| Q4 2023 | 22 | $21.5bn | 10 | 11 |
| Q1 2024 | 30 | $20.3bn | 17 | 12 |
| Q2 2024 | 28 | $18.5bn | 15 | 14 |
| Q3 2024 | 29 | $24.2bn | 15 | 15 |
| Q4 2024 | 28 | $25.9bn | 14 | 14 |
| Q1 2025 | 33 | $32.0bn | 21 | 12 |
| Q2 2025 | 27 | $30.9bn | 18 | 10 |
| Q3 2025 | 23 | $29.4bn | 9 | 14 |
| Q4 2025 | 25 | $34.3bn | 18 | 19 |
| Q1 2026 | 25 | $38.5bn | 16 | 21 |
| Q2 2026 | 26 | $34.2bn | 22 | 16 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
GILD and AMGN →GILD and ARGX →GILD and RVMD →Choose a stock to compare with GILD →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own GILD, latest filings →Back to the 13F Explorer →